8 February 2019
Restoring neurological function after a stroke takes centre stage
Other interesting advances last year involved stem cell therapies for improving clinical outcomes.
Focus:
Comment
-
8 February 2019
Immuno-oncology sees solid growth spurt
In an increasingly competitive landscape, immuno-oncology developers are taking multiple approaches to differentiate their products.
-
8 February 2019
Ophthalmology drug innovation is stuck in the slow lane
The ophthalmology market saw three new drugs reach the market and seven pipeline drugs get pulled from clinical development last year.
-
8 February 2019
Positive outcomes for neurology despite setbacks for Alzheimer’s disease
There have been some R&D setbacks in neurology, most notably in the field of Alzheimer’s disease, which continues to be plagued by drug failures.
-
5 February 2019
FDA prepares for expected surge in gene therapy trials
The surge in the number of gene therapy products has been attributed to the development of safe and effective vectors delivering these products into the human body.
-
5 February 2019
Young adults with cancer need clinical pathways
Patients ages 15–39, having transitioned from the end of childhood into adulthood but without joining the heavily studied “older patient” demographic, tend to get stuck in a treatment impasse.
-
5 February 2019
Takeda’s dengue milestone is a time for cautious optimism
GlobalData believes these results should be treated with cautious optimism.
-
5 February 2019
Approval of Imbruvica bodes well for cancer treatment in 2019
AbbVie and Johnson & Johnson expect total sales of Imbruvica to reach $3.6 billion in 2019.
-
5 February 2019
Four anti-BCMA biologics expected to net $10 billion in revenue by 2027
GlobalData anticipates the total revenues from these four therapies to be approximately $10 billion, which will make up 35% of total MM drug revenues by 2027.
-
4 February 2019
World Cancer Day 2019: the oncology pricing debate continues
This year’s World Cancer Day occurs on 4 February, which also marks the launch of the three-year ‘I Am and I Will’ campaign urging for continued long-lasting impact, global awareness...